General Catalyst Group Management, LLC AVBP Holdings History
General Catalyst Group Management, LLC's ArriVent BioPharma Inc Holding Summary
As of 2025-03-31, General Catalyst Group Management, LLC held 1.49 Mil shares of ArriVent BioPharma Inc(AVBP), totaling $27.64 Mil. This investment constitutes 3.11% of their stock portfolio, and General Catalyst Group Management, LLC now holds 4.39% of the outstanding ArriVent BioPharma Inc(AVBP) stock.
The initial trade took place in 2024Q1. And since then General Catalyst Group Management, LLC has made 1 purchases of AVBP, at an average price of $20.17, for a total of 1.49 Mil shares. Based on historical transaction data and AVBP's current price of $20.17, General Catalyst Group Management, LLC's estimated gain on his AVBP holdings is $-, reflecting a 0.00% gain to date.
General Catalyst Group Management, LLC AVBP ($20.17) Holding Chart
General Catalyst Group Management, LLC AVBP ($20.17) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
